The news: Hims & Hers is rolling out AI-powered health guidance backed by providers and care teams inside its Hers app, starting with members of its women's weight loss programs. Enrolled members can share their goals, medications, and where they are in their care journey with the new tool for personalized guidance. Hims & Hers is also giving these members a smart scale that syncs weight and GLP-1 tracking progress at no added cost.

Why it matters: Hims & Hers is tapping into demand for AI health information and guidance that's already established. Health and wellness advice is the top reason consumers turn to AI for personal guidance, cited by 49% of AI guidance users in EMARKETER's May 2026 survey of US consumers.

Hims & Hers doesn't publicly break out weight loss subscriptions by gender, but November 2025 KFF data revealed that 22% of women have ever used a GLP-1 medication, versus 14% of men. This suggests women may also be a disproportionately valuable audience for the company's AI-powered health tools, as GLP-1 treatment often requires ongoing coaching, symptom management, and personalized guidance.

Implications for healthcare companies: Hims & Hers joins a growing list of online healthcare companies and providers rolling out AI health coaching inside their apps. Like most competitors, it emphasizes that its AI is backed by clinicians when needed, a distinction from general-purpose tools that give health information without clinical oversight. That distinction matters: Misuse of consumer AI chatbots for health without appropriate safeguards is ECRI's top health technology hazard for 2026.

The feature should add value for women already enrolled in Hims & Hers' weight loss program, but it's unlikely to draw new customers on its own. AI-powered tracking and lifestyle guidance are becoming standard in digital health, especially in the crowded online weight loss market, where Noom and WeightWatchers are embedding AI insights into their programs.

The opportunity mostly lies in retention. As GLP-1 competition increasingly shifts from drug access to service quality, companies that pair AI convenience with visible clinical backing and speak to underserved segments like women's health can build loyalty among existing members even without winning many new ones.

This content is part of EMARKETER’s subscription Briefings, where we pair daily updates with data and analysis from forecasts and research reports. Our Briefings prepare you to start your day informed, to provide critical insights in an important meeting, and to understand the context of what’s happening in your industry. Not a subscriber? Click here to get a demo of our full platform and coverage.